Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults

Clinical Nutrition

Volumn 31, Issue 2, 2012, Pages 217-223

  Xu, Ziwei ^a   Li, Yousheng ^a   Wang, Jian ^a   Wu, Bo ^b   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

Cholestasis; Omega 3 polyunsaturated fatty acids; Parenteral nutrition associated liver disease; Short bowel syndrome

Indexed keywords

LIPID EMULSION; OMEGA 3 FATTY ACID; SOYBEAN OIL;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; INTRAHEPATIC CHOLESTASIS; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIVER BIOPSY; LIVER DISEASE; LIVER FUNCTION; LIVER HISTOLOGY; MALE; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; SHORT BOWEL SYNDROME;

ADULT; BILIRUBIN; BIOPSY; CHOLESTASIS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PARENTERAL NUTRITION; SHORT BOWEL SYNDROME; SOYBEAN OIL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84858748287     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.10.001     Document Type: Article

References (32)

1. Freund H.R. Abnormalities of liver function and hepatic damage associated with total parenteral nutrition. Nutrition 1991, 7:1-5.
2. Kelly D.A. Intestinal failure-associated liver disease: what do we know today?. Gastroenterology 2006, 130:S70-S77.
3. Carter B.A., Shulman R.J. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol 2007, 4:277-287.
4. Llop J.M., Virgili N., Moreno-Villares J.M., et al. Phytosterolemia in parenteral nutrition patients: implications for liver disease development. Nutrition 2008, 24:1145-1152.
5. Carter B.A., Taylor O.A., Prendergast D.R., et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 2007, 62:301-306.
6. Alwayn I.P., Gura K., Nose V., et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res 2005, 57:445-452.
7. Diamond I.R., Sterescu A., Pencharz P.B., Kim J.H., Wales P.W. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009, 48:209-215.
8. de Meijer V.E., Le H.D., Meisel J.A., Gura K.M., Puder M. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr 2010, 50:212-218.
9. Puder M., Valim C., Meisel J.A., et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009 Sep, 250:395-402.
10. Lee S.I., Valim C., Johnston P., et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res 2009, 66:698-703.
11. Gura K.M., Lee S., Valim C., et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008, 121:e678-e686.
12. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
13. Kelly D.A. Liver complications of pediatric parenteral nutrition-epidemiology. Nutrition 1998, 14:153-157.
14. Buchman A. Total parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr 2002, 26:S43-S48.
15. Kelly D.A. Preventing parenteral nutrition liver disease. Early Hum Dev 2010, 86:683-687.
16. Wales P.W., de Silva N., Kim J.H., Lecce L., Sandhu A., Moore A.M. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg 2005, 40:755-762.
17. Le H.D., de Meijer V.E., Robinson E.M., et al. Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am J Clin Nutr 2011.
18. Pedersen M.H., Molgaard C., Hellgren L.I., Lauritzen L. Effects of fish oil supplementation on markers of the metabolic syndrome. J Pediatr 2010, 157:395-400. e1.
19. Fujioka S., Hamazaki K., Itomura M., et al. The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects - a randomized, placebo-controlled, double-blind study. J Nutr Sci Vitaminol (Tokyo) 2006, 52:261-265.
20. Fitzgibbons S.C., Jones B.A., Hull M.A., et al. Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome. J Pediatr Surg 2010, 45:95-99. [discussion 9].
21. Jonker J.W., Liddle C., Downes M. FXR and Pxr: potential therapeutic targets in cholestasis. J Steroid Biochem Mol Biol 2011.
22. Sinal C.J., Tohkin M., Miyata M., Ward J.M., Lambert G., Gonzalez F.J. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000, 102:731-744.
23. Eloranta J.J., Kullak-Ublick G.A. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 2005, 433:397-412.
24. Clayton P.T., Bowron A., Mills K.A., Massoud A., Casteels M., Milla P.J. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993, 105:1806-1813.
25. Ellegard L., Sunesson A., Bosaeus I. High serum phytosterol levels in short bowel patients on parenteral nutrition support. Clin Nutr 2005, 24:415-420.
26. Zhao A., Yu J., Lew J.L., Huang L., Wright S.D., Cui J. Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets. DNA Cell Biol 2004, 23:519-526.
27. de Meijer V.E., Gura K.M., Le H.D., Meisel J.A., Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr 2009, 33:541-547.
28. Fallon E.M., Le H.D., Puder M. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant 2010, 15:334-340.
29. Diamond I.R., Sterescu A., Pencharz P.B., Wales P.W. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr Surg Int 2008, 24:773-778.
30. Furst P., Kuhn K.S. Fish oil emulsions: what benefits can they bring?. Clin Nutr 2000, 19:7-14.
31. Biolo G., Grimble G., Preiser J.C., et al. Position paper of the ESICM Working Group on Nutrition and Metabolism. Metabolic basis of nutrition in intensive care unit patients: ten critical questions. Intensive Care Med 2002, 28:1512-1520.
32. Hermans D., Talbotec C., Lacaille F., Goulet O., Ricour C., Colomb V. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 2007, 44:459-463.